Clinical, virological, and operational aspects of a single-center Belgian experience with in-hospital infusions of casirivimab/imdevimab and sotrovimab for mild/moderate COVID-19

Sandrine Milasa Department of Internal Medicine and Infectious Diseases, Charleroi University Hospital, Charleroi, BelgiumCorrespondence[email protected]

https://orcid.org/0000-0002-7228-3527

Christophe Lelubrea Department of Internal Medicine and Infectious Diseases, Charleroi University Hospital, Charleroi, Belgium

Fabrizio Buttafuocoa Department of Internal Medicine and Infectious Diseases, Charleroi University Hospital, Charleroi, Belgium

Alberto Papaleoa Department of Internal Medicine and Infectious Diseases, Charleroi University Hospital, Charleroi, Belgium

Salah Eddine Lalib Department of Microbiology Laboratory, Charleroi University Hospital, Charleroi, Belgium

Anne Tamigniaub Department of Microbiology Laboratory, Charleroi University Hospital, Charleroi, Belgium

Soraya Cherifia Department of Internal Medicine and Infectious Diseases, Charleroi University Hospital, Charleroi, Belgium

show all

Citations (0)

Keep up to date with the latest research on this topic with citation updates for this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical, virological, and operational aspects of a single-center Belgian experience with in-hospital infusions of casirivimab/imdevimab and sotrovimab for mild/moderate COVID-19

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical, virological, and operational aspects of a single-center Belgian experience with in-hospital infusions of casirivimab/imdevimab and sotrovimab for mild/moderate COVID-19

Citations (0)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date